Table of Content

1 Report Overview

1.1 Objectives of the Study

1.2 Introduction to Biobanking Market

1.3 What This Report Delivers

1.4 Why You Should Read This Report

1.5 Key Questions Answered by This Analytical Report Include:

1.6 Who is This Report For?

1.7 Methodology

1.7.1 Market Definitions

1.7.2 Market Evaluation & Forecasting Methodology

1.7.3 Data Validation

1.7.3.1 Primary Research

1.7.3.2 Secondary Research

1.8 Frequently Asked Questions (FAQs)

2 Executive Summary

 

3 Market Overview

3.1 Key Findings

3.2 Market Dynamics

3.2.1 Market Driving Factors

3.2.1.1 Increased Focus on Precision Medicine and Genetic Testing

3.2.1.2 Growing Demand for Umbilical Cord Blood Banking

3.2.1.3 Evolution of Biobanks Rapidly Enabling Massive Collections of Biological Materials and Associated Information

3.2.2 Market Restraining Factors

3.2.2.1 Private Sponsorship Has Raised a Number of Ethical Issues

3.2.2.2 Issues Related to Biospecimen Sample Procurement

3.2.2.3 Long-term Sustainability of Biobanks

3.2.3 Market Opportunities

3.2.3.1 Human Biospecimens are Essential for Progress in Biomarker Discovery and Customised Treatment

3.2.3.2 Opportunities for Cardiovascular Research

3.2.3.3 Growing Focus on the R&D of Cell Therapies

3.3 COVID-19 Impact Analysis

3.4 Porter’s Five Forces Analysis

3.4.1 Bargaining Power of Suppliers

3.4.2 Bargaining Power of Buyers

3.4.3 Competitive Rivalry

3.4.4 Threat of Substitutes

3.4.5 Threat of New Entrants

3.5 PEST Analysis

 

4 Biobanking Market Analysis by Ownership

4.1 Key Findings

4.2 Ownership Segment: Market Attractiveness Index

4.3 Biobanking Market Size Estimation and Forecast by Ownership

4.4 National/Regional Agencies

4.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

4.4.2 Market Share by Region, 2024 & 2034 (%)

4.5 Universities

4.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

4.5.2 Market Share by Region, 2024 & 2034 (%)

4.6 Non-profit

4.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

4.6.2 Market Share by Region, 2024 & 2034 (%)

4.7 Private

4.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

4.7.2 Market Share by Region, 2024 & 2034 (%)

 

5 Biobanking Market Analysis by Sample

5.1 Key Findings

5.2 Sample Segment: Market Attractiveness Index

5.3 Biobanking Market Size Estimation and Forecast by Sample

5.4 Blood Products

5.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

5.4.2 Market Share by Region, 2024 & 2034 (%)

5.5 Human Tissues

5.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

5.5.2 Market Share by Region, 2024 & 2034 (%)

5.6 Nucleic Acids

5.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

5.6.2 Market Share by Region, 2024 & 2034 (%)

5.7 Cell Lines

5.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

5.7.2 Market Share by Region, 2024 & 2034 (%)

5.8 Biological Fluids

5.8.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

5.8.2 Market Share by Region, 2024 & 2034 (%)

5.9 Others

5.9.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

5.9.2 Market Share by Region, 2024 & 2034 (%)

 

6 Biobanking Market Analysis by Application

6.1 Key Findings

6.2 Application Segment: Market Attractiveness Index

6.3 Biobanking Market Size Estimation and Forecast by Application

6.4 Regenerative Medicine

6.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

6.4.2 Market Share by Region, 2024 & 2034 (%)

6.5 Life Science Research

6.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

6.5.2 Market Share by Region, 2024 & 2034 (%)

6.6 Clinical Research

6.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

6.6.2 Market Share by Region, 2024 & 2034 (%)

 

7 Biobanking Market Analysis by Product and Service

7.1 Key Findings

7.2 Product and Service Segment: Market Attractiveness Index

7.3 Biobanking Market Size Estimation and Forecast by Product and Service

7.4 Equipment

7.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

7.4.2 Market Share by Region, 2024 & 2034 (%)

7.5 Consumables

7.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

7.5.2 Market Share by Region, 2024 & 2034 (%)

7.6 Services

7.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

7.6.2 Market Share by Region, 2024 & 2034 (%)

7.7 Software

7.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

7.7.2 Market Share by Region, 2024 & 2034 (%)

 

8 Biobanking Market Analysis by End-users

8.1 Key Findings

8.2 End-users Segment: Market Attractiveness Index

8.3 Biobanking Market Size Estimation and Forecast by End-users

8.4 Pharmaceutical & Biotechnology Companies

8.4.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

8.4.2 Market Share by Region, 2024 & 2034 (%)

8.5 CROs

8.5.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

8.5.2 Market Share by Region, 2024 & 2034 (%)

8.6 Academic & Research Institutes

8.6.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

8.6.2 Market Share by Region, 2024 & 2034 (%)

8.7 Hospitals

8.7.1 Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

8.7.2 Market Share by Region, 2024 & 2034 (%)

 

9 Biobanking Market Analysis by Region

9.1 Key Findings

9.2 Regional Market Size Estimation and Forecast

 

10 North America Biobanking Market Analysis

10.1 Key Findings

10.2 North America Biobanking Market Attractiveness Index

10.3 North America Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)

10.4 North America Biobanking Market Size Estimation and Forecast by Country

10.5 North America Biobanking Market Size Estimation and Forecast by Ownership

10.6 North America Biobanking Market Size Estimation and Forecast by Sample

10.7 North America Biobanking Market Size Estimation and Forecast by Application

10.8 North America Biobanking Market Size Estimation and Forecast by Product and Service

10.9 North America Biobanking Market Size Estimation and Forecast by End-users

10.10 U.S. Biobanking Market Analysis

10.11 Canada Biobanking Market Analysis

 

11 Europe Biobanking Market Analysis

11.1 Key Findings

11.2 Europe Biobanking Market Attractiveness Index

11.3 Europe Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)

11.4 Europe Biobanking Market Size Estimation and Forecast by Country

11.5 Europe Biobanking Market Size Estimation and Forecast by Ownership

11.6 Europe Biobanking Market Size Estimation and Forecast by Sample

11.7 Europe Biobanking Market Size Estimation and Forecast by Application

11.8 Europe Biobanking Market Size Estimation and Forecast by Product and Service

11.9 Europe Biobanking Market Size Estimation and Forecast by End-users

11.10 Germany Biobanking Market Analysis

11.11 UK Biobanking Market Analysis

11.12 France Biobanking Market Analysis

11.13 Italy Biobanking Market Analysis

11.14 Spain Biobanking Market Analysis

11.15 Russia Biobanking Market Analysis

11.16 Rest of Europe Biobanking Market Analysis

 

12 Asia Pacific Biobanking Market Analysis

12.1 Key Findings

12.2 Asia Pacific Biobanking Market Attractiveness Index

12.3 Asia Pacific Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)

12.4 Asia Pacific Biobanking Market Size Estimation and Forecast by Country

12.5 Asia Pacific Biobanking Market Size Estimation and Forecast by Ownership

12.6 Asia Pacific Biobanking Market Size Estimation and Forecast by Sample

12.7 Asia Pacific Biobanking Market Size Estimation and Forecast by Application

12.8 Asia Pacific Biobanking Market Size Estimation and Forecast by Product and Service

12.9 Asia Pacific Biobanking Market Size Estimation and Forecast by End-users

12.10 Japan Biobanking Market Analysis

12.11 China Biobanking Market Analysis

12.12 India Biobanking Market Analysis

12.13 Australia Biobanking Market Analysis

12.14 South Korea Biobanking Market Analysis

12.15 South-East Asia Biobanking Market Analysis

12.16 Rest of Asia Pacific Biobanking Market Analysis

 

13 Latin America Biobanking Market Analysis

13.1 Key Findings

13.2 Latin America Biobanking Market Attractiveness Index

13.3 Latin America Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)

13.4 Latin America Biobanking Market Size Estimation and Forecast by Country

13.5 Latin America Biobanking Market Size Estimation and Forecast by Ownership

13.6 Latin America Biobanking Market Size Estimation and Forecast by Sample

13.7 Latin America Biobanking Market Size Estimation and Forecast by Application

13.8 Latin America Biobanking Market Size Estimation and Forecast by Product and Service

13.9 Latin America Biobanking Market Size Estimation and Forecast by End-users

13.10 Brazil Biobanking Market Analysis

13.11 Mexico Biobanking Market Analysis

13.12 Rest of Latin America Biobanking Market Analysis

 

14 MEA Biobanking Market Analysis

14.1 Key Findings

14.2 MEA Biobanking Market Attractiveness Index

14.3 MEA Biobanking Market by Country, 2024, 2029 & 2034 (US$ Billion)

14.4 MEA Biobanking Market Size Estimation and Forecast by Country

14.5 MEA Biobanking Market Size Estimation and Forecast by Ownership

14.6 MEA Biobanking Market Size Estimation and Forecast by Sample

14.7 MEA Biobanking Market Size Estimation and Forecast by Application

14.8 MEA Biobanking Market Size Estimation and Forecast by Product and Service

14.9 MEA Biobanking Market Size Estimation and Forecast by End-users

14.10 GCC Biobanking Market Analysis

14.11 South Africa Biobanking Market Analysis

14.12 Rest of MEA Biobanking Market Analysis

 

15 Company Profiles

15.1 Thermo Fisher Scientific, Inc.

15.1.1 Company Snapshot

15.1.2 Company Overview

15.1.3 Financial Analysis

15.1.3.1 Net Revenue, 2015-2022

15.1.3.2 Regional Market Shares, 2022

15.1.3.3 R&D, 2015-2022

15.1.4 Product Benchmarking

15.2 PHC Holdings Corporation

15.2.1 Company Snapshot

15.2.2 Company Overview

15.2.3 Product Benchmarking

15.2.4 Strategic Outlook

15.3 Hamilton Company

15.3.1 Company Snapshot

15.3.2 Company Overview

15.3.3 Product Benchmarking

15.4 Avantor Inc.

15.4.1 Company Snapshot

15.4.2 Company Overview

15.4.3 Financial Analysis

15.4.3.1 Net Revenue, 2015-2022

15.4.3.2 Regional Market Shares, 2022

15.4.4 Product Benchmarking

15.5 Qiagen N.V.

15.5.1 Company Snapshot

15.5.2 Company Overview

15.5.3 Financial Analysis

15.5.3.1 Net Revenue, 2015-2022

15.5.3.2 Regional Market Shares, 2022

15.5.3.3 R&D, 2015-2022

15.5.4 Product Benchmarking

15.6 Tecan Trading AG

15.6.1 Company Snapshot

15.6.2 Company Overview

15.6.3 Product Benchmarking

15.7 Merck & Co., Inc.

15.7.1 Company Snapshot

15.7.2 Company Overview

15.7.3 Financial Analysis

15.7.3.1 Net Revenue, 2015-2022

15.7.3.2 Regional Market Shares, 2022

15.7.3.3 R&D, 2015-2022

15.7.4 Product Benchmarking

15.8 Cryoport Inc.

15.8.1 Company Snapshot

15.8.2 Company Overview

15.8.3 Financial Analysis

15.8.3.1 Net Revenue, 2015-2022

15.8.3.2 Regional Market Shares, 2022

15.8.3.3 R&D, 2015-2022

15.8.4 Product Benchmarking

15.8.5 Strategic Outlook

15.9 Azenta Inc.

15.9.1 Company Snapshot

15.9.2 Company Overview

15.9.3 Financial Analysis

15.9.3.1 Net Revenue, 2015-2022

15.9.3.2 R&D, 2015-2022

15.9.4 Product Benchmarking

15.10 Isenet Biobanking

15.10.1 Company Snapshot

15.10.2 Company Overview

15.10.3 Product Benchmarking

15.11 CTI Biotech

15.11.1 Company Snapshot

15.11.2 Company Overview

15.11.3 Product Benchmarking

15.12 Boca Biolistics

15.12.1 Company Snapshot

15.12.2 Company Overview

15.12.3 Product Benchmarking

15.12.4 Strategic Outlook

15.13 BIOIVT & ELEVATING SCIENCE

15.13.1 Company Snapshot

15.13.2 Company Overview

15.13.3 Product Benchmarking

15.13.4 Strategic Outlook

15.14 US Biolab Corp. Inc.

15.14.1 Company Snapshot

15.14.2 Company Overview

15.14.3 Product Benchmarking

15.15 ProteoGenex Inc.

15.15.1 Company Snapshot

15.15.2 Company Overview

15.15.3 Product Benchmarking

15.16 ASKION GmbH

15.16.1 Company Snapshot

15.16.2 Company Overview

15.16.3 Product Benchmarking

 

16 Conclusion and Recommendations

16.1 Concluding Remarks from Visiongain

16.2 Recommendations for Market Players

 

List of Tables

Table 1 Biobanking Market Snapshot, 2024 & 2034 (US$ Billion, CAGR %)

Table 2 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "V" Shaped Recovery

Table 3 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "U" Shaped Recovery

Table 4 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "W" Shaped Recovery

Table 5 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%): "L" Shaped Recovery

Table 6 Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 7 National/Regional Agencies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 8 Universities Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 9 Non-profit Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 10 Private Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 11 Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 12 Blood Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 13 Human Tissues Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 14 Nucleic Acid Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 15 Cell Lines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 16 Biological Fluids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 17 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 18 Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 19 Regenerative Medicine Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 20 Life Science Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 21 Clinical Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 22 Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 23 Equipment Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 24 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 25 Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 26 Software Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 27 Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 28 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 29 CROs Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 30 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 31 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 32 Biobanking Market Forecast by Region, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 33 North America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 34 North America Biobanking Market Forecast by Type, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 35 North America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 36 North America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 37 North America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 38 North America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 39 U.S. Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 40 Canada Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 41 Europe Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 42 Europe Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 43 Europe Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 44 Europe Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 45 Europe Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 46 Europe Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 47 Germany Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 48 UK Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 49 France Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 50 Italy Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 51 Spain Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 52 Russia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 53 Rest of Europe Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 54 Asia Pacific Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 55 Asia Pacific Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 56 Asia Pacific Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 57 Asia Pacific Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 58 Asia Pacific Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 59 Asia Pacific Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 60 Japan Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 61 China Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 62 India Biobanking Institutes

Table 63 India Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 64 Australia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 65 South Korea Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 66 South-East Asia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 67 Rest of Asia Pacific Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 68 Latin America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 69 Latin America Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 70 Latin America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 71 Latin America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 72 Latin America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 73 Latin America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 74 Brazil Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 75 Mexico Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 76 Rest of Latin America Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 77 MEA Biobanking Market Forecast by Country, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 78 MEA Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 79 MEA Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 80 MEA Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 81 MEA Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 82 MEA Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 83 GCC Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 84 South Africa Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 85 Rest of MEA Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR%, CAGR%)

Table 86 Thermo Fisher Scientific, Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 87 Thermo Fisher Scientific, Inc.: Product Benchmarking

Table 88 PHC Holdings Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 89 PHC Holdings Corporation: Product Benchmarking

Table 90 PHC Holdings Corporation: Strategic Outlook

Table 91 Hamilton Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 92 Hamilton Company: Product Benchmarking

Table 93 Avantor Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 94 Avantor Inc.: Product Benchmarking

Table 95 Qiagen N.V.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 96 Qiagen N.V.: Product Benchmarking

Table 97 Tecan Trading AG: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 98 Tecan Trading AG: Product Benchmarking

Table 99 Merck & Co., Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 100 Merck & Co., Inc.: Product Benchmarking

Table 101 Cryoport Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 102 Cryoport Inc.: Product Benchmarking

Table 103 Cryoport Inc.: Strategic Outlook

Table 104 Azenta Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 105 Azenta Inc.: Product Benchmarking

Table 106 Isenet Biobanking: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 107 Isenet Biobanking: Product Benchmarking

Table 108 CTI Biotech: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 109 CTI Biotech: Product Benchmarking

Table 110 Boca Biolistics: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 111 Boca Biolistics: Product Benchmarking

Table 112 Boca Biolistics: Strategic Outlook

Table 113 BIOIVT & ELEVATING SCIENCE: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 114 BIOIVT & ELEVATING SCIENCE: Product Benchmarking

Table 115 BIOIVT & ELEVATING SCIENCE: Strategic Outlook

Table 116 US Biolab Corp. Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 117 US Biolab Corp. Inc.: Product Benchmarking

Table 118 ProteoGenex Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 119 ProteoGenex Inc.: Product Benchmarking

Table 120 ASKION GmbH: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)

Table 121 ASKION GmbH: Product Benchmarking

 

List of Figures

Figure 1 Biobanking Market Segmentation

Figure 2 Biobanking Market by Ownership: Market Attractiveness Index

Figure 3 Biobanking Market by Sample: Market Attractiveness Index

Figure 4 Biobanking Market by Application: Market Attractiveness Index

Figure 5 Biobanking Market by Product and Service: Market Attractiveness Index

Figure 6 Biobanking Market by End-users: Market Attractiveness Index

Figure 7 Biobanking Market Attractiveness Index by Region

Figure 8 Biobanking Market: Market Dynamics

Figure 9 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): “V” Shaped Recovery

Figure 10 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): “U” Shaped Recovery

Figure 11 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): “W” Shaped Recovery

Figure 12 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %): “L” Shaped Recovery

Figure 13 Biobanking Market: Porter’s Five Forces Analysis

Figure 14 Biobanking Market: PEST Analysis

Figure 15 Biobanking Market Attractiveness Index by Ownership

Figure 16 Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)

Figure 17 Biobanking Market Share Forecast by Ownership, 2024, 2029, 2034 (%)

Figure 18 National/Regional Agencies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 19 National/Regional Agencies Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 20 Universities Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 21 Universities Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 22 Non-profit Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 23 Non-profit Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 24 Private Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 25 Private Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 26 Biobanking Market Attractiveness Index by Ownership

Figure 27 Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)

Figure 28 Biobanking Market Share Forecast by Sample, 2024, 2029, 2034 (%)

Figure 29 Blood Products Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 30 Blood Products Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 31 Human Tissues Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 32 Human Tissues Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 33 Nucleic Acids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 34 Nucleic Acids Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 35 Cell Lines Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 36 Cell Lines Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 37 Biological Fluids Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 38 Biological Fluids Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 39 Others Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 40 Others Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 41 Biobanking Market Attractiveness Index by Application

Figure 42 Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)

Figure 43 Biobanking Market Share Forecast by Application, 2024, 2029, 2034 (%)

Figure 44 Regenerative Medicine Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 45 Regenerative Medicine Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 46 Life Science Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 47 Life Science Research Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 48 Clinical Research Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 49 Clinical Research Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 50 Biobanking Market Attractiveness Index by Product and Service

Figure 51 Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)

Figure 52 Biobanking Market Share Forecast by Product and Service, 2024, 2029, 2034 (%)

Figure 53 Equipment Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 54 Equipment Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 55 Consumables Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 56 Consumables Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 57 Services Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 58 Services Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 59 Software Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 60 Software Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 61 Biobanking Market Attractiveness Index by End-users

Figure 62 Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)

Figure 63 Biobanking Market Share Forecast by End-users, 2024, 2029, 2034 (%)

Figure 64 Pharmaceutical & Biotechnology Companies Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 65 Pharmaceutical & Biotechnology Companies Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 66 CROs Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 67 CROs Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 68 Academic & Research Institutes Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 69 Academic & Research Institutes Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 70 Hospitals Segment Market Forecast by Region, 2024-2034 (US$ Billion, AGR %)

Figure 71 Hospitals Segment Market Share Forecast by Region, 2024 & 2034 (%)

Figure 72 Biobanking Market Forecast by Region 2024, 2029, 2034 (Revenue, CAGR%)

Figure 73 Biobanking Market Share Forecast by Region 2024, 2029, 2034 (%)

Figure 74 Biobanking Market by Region, 2024-2034 (US$ Billion, AGR %)

Figure 75 North America Biobanking Market Attractiveness Index

Figure 76 North America Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)

Figure 77 North America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)

Figure 78 North America Biobanking Market Share Forecast by Country, 2024 & 2034 (%)

Figure 79 North America Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)

Figure 80 North America Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)

Figure 81 North America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)

Figure 82 North America Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)

Figure 83 North America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)

Figure 84 North America Biobanking Market Share Forecast by Application, 2024 & 2034 (%)

Figure 85 North America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)

Figure 86 North America Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)

Figure 87 North America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)

Figure 88 North America Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)

Figure 89 U.S. Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 90 Canada Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 91 Europe Biobanking Market Attractiveness Index

Figure 92 Europe Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)

Figure 93 Europe Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)

Figure 94 Europe Biobanking Market Share Forecast by Country, 2024 & 2034 (%)

Figure 95 Europe Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)

Figure 96 Europe Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)

Figure 97 Europe Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)

Figure 98 Europe Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)

Figure 99 Europe Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)

Figure 100 Europe Biobanking Market Share Forecast by Application, 2024 & 2034 (%)

Figure 101 Europe Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)

Figure 102 Europe Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)

Figure 103 Europe Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)

Figure 104 Europe Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)

Figure 105 Germany Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 106 UK Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 107 France Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 108 Italy Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 109 Spain Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 110 Russia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 111 Rest of Europe Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 112 Asia Pacific Biobanking Market Attractiveness Index

Figure 113 Asia Pacific Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)

Figure 114 Asia Pacific Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)

Figure 115 Asia Pacific Biobanking Market Share Forecast by Country, 2024 & 2034 (%)

Figure 116 Asia Pacific Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)

Figure 117 Asia Pacific Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)

Figure 118 Asia Pacific Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)

Figure 119 Asia Pacific Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)

Figure 120 Asia Pacific Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)

Figure 121 Asia Pacific Biobanking Market Share Forecast by Application, 2024 & 2034 (%)

Figure 122 Asia Pacific Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)

Figure 123 Asia Pacific Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)

Figure 124 Asia Pacific Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)

Figure 125 Asia Pacific Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)

Figure 126 Japan Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 127 China Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 128 India Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 129 Australia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 130 South Korea Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 131 South-East Asia Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 132 Rest of Asia Pacific Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 133 Latin America Biobanking Market Attractiveness Index

Figure 134 Latin America Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)

Figure 135 Latin America Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)

Figure 136 Latin America Biobanking Market Share Forecast by Country, 2024 & 2034 (%)

Figure 137 Latin America Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)

Figure 138 Latin America Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)

Figure 139 Latin America Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)

Figure 140 Latin America Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)

Figure 141 Latin America Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)

Figure 142 Latin America Biobanking Market Share Forecast by Application, 2024 & 2034 (%)

Figure 143 Latin America Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)

Figure 144 Latin America Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)

Figure 145 Latin America Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)

Figure 146 Latin America Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)

Figure 147 Brazil Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 148 Mexico Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 149 Rest of Latin America Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 150 MEA Biobanking Market Attractiveness Index

Figure 151 MEA Biobanking Market by Region, 2024, 2029 & 2034 (US$ Billion)

Figure 152 MEA Biobanking Market Forecast by Country, 2024-2034 (US$ Billion)

Figure 153 MEA Biobanking Market Share Forecast by Country, 2024 & 2034 (%)

Figure 154 MEA Biobanking Market Forecast by Ownership, 2024-2034 (US$ Billion, AGR %)

Figure 155 MEA Biobanking Market Share Forecast by Ownership, 2024 & 2034 (%)

Figure 156 MEA Biobanking Market Forecast by Sample, 2024-2034 (US$ Billion, AGR %)

Figure 157 MEA Biobanking Market Share Forecast by Sample, 2024 & 2034 (%)

Figure 158 MEA Biobanking Market Forecast by Application, 2024-2034 (US$ Billion, AGR %)

Figure 159 MEA Biobanking Market Share Forecast by Application, 2024 & 2034 (%)

Figure 160 MEA Biobanking Market Forecast by Product and Service, 2024-2034 (US$ Billion, AGR %)

Figure 161 MEA Biobanking Market Share Forecast by Product and Service, 2024 & 2034 (%)

Figure 162 MEA Biobanking Market Forecast by End-users, 2024-2034 (US$ Billion, AGR %)

Figure 163 MEA Biobanking Market Share Forecast by End-users, 2024 & 2034 (%)

Figure 164 GCC Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 165 South Africa Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 166 Rest of MEA Biobanking Market Forecast, 2024-2034 (US$ Billion, AGR %)

Figure 167 Thermo Fisher Scientific, Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)

Figure 168 Thermo Fisher Scientific, Inc.: Regional Market Shares (%), 2022

Figure 169 Thermo Fisher Scientific, Inc.: R&D, 2015-2022 (US$ Million, AGR%)

Figure 170 Avantor Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)

Figure 171 Avantor Inc.: Regional Market Shares (%), 2022

Figure 172 Qiagen N.V.: Net Revenue, 2015-2022 (US$ Million, AGR%)

Figure 173 Qiagen N.V.: Regional Market Shares (%), 2022

Figure 174 Qiagen N.V.: R&D, 2015-2022 (US$ Million, AGR%)

Figure 175 Merck & Co., Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)

Figure 176 Merck & Co., Inc.: Regional Market Shares (%), 2022

Figure 177 Merck & Co., Inc.: R&D, 2015-2022 (US$ Million, AGR%)

Figure 178 Cryoport Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)

Figure 179 Cryoport Inc.: Regional Market Shares (%), 2022

Figure 180 Cryoport Inc.: R&D, 2015-2022 (US$ Million, AGR%)

Figure 181 Azenta Inc.: Net Revenue, 2015-2022 (US$ Million, AGR%)

Figure 182 Azenta Inc.: R&D, 2015-2022 (US$ Million, AGR%)